STOCK TITAN

Saba boosts stake in Gabelli Healthcare & WellnessRx (NYSE: GRX)

(High)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust (GRX) received an amended Schedule 13D (Amendment No. 4) reporting that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein (together, the reporting persons) beneficially own 2,155,133 common shares of GRX. This represents 14.32% of GRX’s common shares, based on 15,050,683 shares outstanding as of 12/31/25 as disclosed in GRX’s N-CSR filed 3/9/26. The reporting persons hold shared voting and shared dispositive power over all of these shares and no sole power. Approximately $20,771,553 in aggregate was paid to acquire the reported shares, funded by investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All transactions in the past 60 days before August 27, 2026 were executed in the open market and are detailed in an attached schedule.

Positive

  • None.

Negative

  • None.

Filing Explained

This Amendment No. 4 changes Items 3, 5, and 7 of the Schedule 13D, while Item 4—Purpose of Transaction—is marked “Not Applicable,” so the filing provides no stated transaction-purpose disclosure alongside its funding, ownership, and transaction history.

Beneficially owned GRX common shares 2,155,133 shares Aggregate common shares beneficially owned by each reporting person
Percentage of GRX common shares outstanding 14.32 % Ownership percentage based on 15,050,683 shares outstanding as of 12/31/25
GRX shares outstanding 15,050,683 shares Common shares outstanding as of 12/31/25 per N-CSR filed 3/9/26
Aggregate acquisition cost $20,771,553 Total consideration paid to acquire the reported GRX common shares
Shared voting power 2,155,133 shares Shares over which each reporting person has shared power to vote
Shared dispositive power 2,155,133 shares Shares over which each reporting person has shared power to dispose
beneficial owner regulatory
"the beneficial owner of the Common Shares reported herein"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Schedule 13D regulatory
"previously filed a statement on Schedule 13G to report the acquisition"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
dispositive power financial
"sole or shared power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
margin account borrowings financial
"and margin account borrowings made in the ordinary course of business"
subscription proceeds financial
"derived from the subscription proceeds from investors and the capital appreciation"
Schedule A regulatory
"are set forth in Schedule A, and are incorporated herein by reference"

FAQ

What ownership stake in GRX does Saba Capital report in this Schedule 13D/A?

Saba Capital and related reporting persons report beneficial ownership of 2,155,133 GRX common shares, representing 14.32% of the company’s outstanding common shares, based on 15,050,683 shares outstanding as of December 31, 2025.

How much did Saba Capital pay to acquire its GRX position?

The reporting persons state that a total of approximately $20,771,553 was paid to acquire the GRX common shares reported in this Schedule 13D/A, funded by investor subscription proceeds, capital appreciation, and ordinary-course margin account borrowings.

What voting and dispositive powers over GRX shares does Saba Capital report?

The reporting persons report 0 shares with sole voting or sole dispositive power and 2,155,133 shares with shared voting and shared dispositive power, corresponding to their entire reported GRX position.

On what share count is Saba’s 14.32% GRX ownership based?

The 14.32% ownership figure is calculated using 15,050,683 GRX common shares outstanding as of December 31, 2025, as disclosed in Gabelli Healthcare & WellnessRx Trust’s N-CSR filed on March 9, 2026.

What is the event date that triggered this GRX Schedule 13D/A amendment?

The date of the event requiring this Schedule 13D/A (Amendment No. 4) filing for GRX is stated as August 27, 2026. Transactions in the prior sixty days before this date are listed in Schedule A to the filing.

What does Amendment No. 4 to the GRX Schedule 13D change?

Amendment No. 4 specifically states that it amends Items 3, 5, and 7, which address the source and amount of funds, interest in GRX securities, and exhibits, including the transaction detail Schedule A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





36246K103

(CUSIP Number)
Saba Capital Management, L.P.
405 Lexington Avenue, 58th Floor, Attention: Michael D'Angelo
New York, NY, 10174
(212) 542-4635

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
08/27/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 15,050,683 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/9/26.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 15,050,683 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/9/26.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 15,050,683 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/9/26.


SCHEDULE 13D


Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:08/28/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:08/28/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:08/28/2026
Comments accompanying signature:
Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823